A prospective phase 2 trial of daratumumab in patients with previously treated systemic light-chain amyloidosis.
Roussel M, Merlini G, Chevret S, Arnulf B, Stoppa AM, Perrot A, Palladini G, Karlin L, Royer B, Huart A, Macro M, Morel P, Frenzel L, Touzeau C, Boyle E, Dorvaux V, Le Bras F, Lavergne D, Bridoux F, Jaccard A.
Roussel M, et al. Among authors: merlini g.
Blood. 2020 Apr 30;135(18):1531-1540. doi: 10.1182/blood.2019004369.
Blood. 2020.
PMID: 32108228
Free article.
Clinical Trial.